Lupin, TB Alliance partner for new therapy for highly drug-resistant TB

Indian pharma company Lupin Limited has secured a non-exclusive license from TB Alliance, a non-profit drug developer, for manufacturing the anti-TB drug pretomanid. Pretomanid is ... Read More